Effects on baseline DAS28 (points) | Effects on annual rate of change in DAS28 (points/year) | |||||
P value | Prevaccination | P value | Post vaccination | P value | ||
Intercept | 2.600±0.211 | <0.001 | −0.038±0.042 | 0.366 | −0.871±1.019 | 0.393 |
Gender (ref. woman) | −0.361±0.099 | <0.001 | −0.026±0.019 | 0.172 | 0.939±0.464 | 0.043 |
Age at vaccination (per year) | 0.010±0.003 | 0.004 | 0.001±0.001 | 0.252 | 0.004±0.016 | 0.800 |
Targeted therapy at vaccination (ref. TNF-i) | −0.066±0.068 | 0.332 | −0.052±0.015 | <0.001 | 0.581±0.372 | 0.118 |
Plus-minus values represent means±SE.
DAS28, Disease Activity Score in 28 joints; RA, rheumatoid arthritis; ref., reference; TNF-i, tumour necrosis factor inhibitor.